Home › Research › Health systems and care delivery
P3‐482: Creation and implementation of the nation's first Alzheimer's disease advantage plan
Jan Dougherty, Pierre N. Tariot, Jenny Keppler, Patricia Dorgan, David J. Martin, Jessica B. S. Langbaum. Alzheimer s & Dementia, 2008-07-01
Topic: Amyloid, tau and blood-test diagnosis
Alzheimer's disease and related dementias are known to affect both the patient and the family caregiver. However, traditional models of medical care provide for limited health care benefits for the patient and virtually no care or benefits for the family. The Centers for Medicare and Medicaid Services (CMS) recently approved the first and only Medicare Advantage plan for Alzheimer's disease and related dementias. The new “special needs population” product model incorporates specialized dementia clinical care for the patient and non-medical support for family caregivers linked to a community case management model in order to manage care of the patient and family across the health care continuum. Families are proactively educated to successfully manage day to day care and are offered a limited respite benefit. Enrollment into the Alzheimer's Association Safe Return program and a prescription formulary to cover antidementia medications are additional unique benefits. Patients with a diagnosis of dementia are eligible for the plan. Upon enrollment, members and their caregivers undergo a detailed case review. In addition, data are collected to assess caregiver burden and depression, the patient's cognition, patient and caregiver quality of life, functional abilities, neuropsychiatric disturbances, and health service needs. These assessments are scheduled to be completed every 6 months over a 2 year evaluation period and will be used to measure the success of the model of care and support. Members enrolling in this new plan are intensively co-managed by the medical team and the identified case manager. This session will overview the components of the unique program that joins a health care provider with dementia specific expertise and a health insurance plan's personalized case management model. The clinical model, training case managers on the administration of standard psychometric assessments and how to become “dementia capable,” utilizing dementia care paths to navigate care will be discussed. In addition, we will outline our plan for data collection, sharing, and how the patient and caregiver outcomes will be used to assess the program's effectiveness. An innovative health care plan for dementia can assist both the patient and the family to achieve optimal outcomes.
Key findings
- Members enrolling in this new plan are intensively co-managed by the medical team and the identified case manager.
- This session will overview the components of the unique program that joins a health care provider with dementia specific expertise and a health insurance plan's personalized case management model.
- The clinical model, training case managers on the administration of standard psychometric assessments and how to become “dementia capable,” utilizing dementia care paths to navigate care will be discussed.
- In addition, we will outline our plan for data collection, sharing, and how the patient and caregiver outcomes will be used to assess the program's effectiveness.
- An innovative health care plan for dementia can assist both the patient and the family to achieve optimal outcomes.
Why it matters
This paper describes the creation of a Medicare Advantage plan for people with Alzheimer's disease and related dementias that includes specialized clinical care and support for family caregivers. It does not test a treatment, cure, or prevention for Alzheimer's disease.
Study details
- Evidence strengthLow
How this study scored 24/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2008 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 20 year(s) since 2008 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Jessica B. S. Langbaum: h-index 39 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Banner Alzheimer’s Institute: institution h-index 243 (OpenAlex) |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 24 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Dougherty, J., Tariot, P. N., Keppler, J., Dorgan, P., Martin, D. J., & Langbaum, J. B. S. (2008). P3‐482: Creation and implementation of the nation's first Alzheimer's disease advantage plan. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2008.05.2053
Vancouver
Dougherty J, Tariot PN, Keppler J, Dorgan P, Martin DJ, Langbaum JBS. P3‐482: Creation and implementation of the nation's first Alzheimer's disease advantage plan. Alzheimer s & Dementia. 2008. doi:10.1016/j.jalz.2008.05.2053.
BibTeX
@article{dougherty2008-d73279a0,
author = {Dougherty, Jan and Tariot, Pierre N. and Keppler, Jenny and Dorgan, Patricia and Martin, David J. and Langbaum, Jessica B. S.},
title = {{P3‐482: Creation and implementation of the nation's first Alzheimer's disease advantage plan}},
journal = {Alzheimer s \& Dementia},
year = {2008},
doi = {10.1016/j.jalz.2008.05.2053},
url = {https://doi.org/10.1016/j.jalz.2008.05.2053}
}
Related studies in Health systems and care delivery
Also in Health systems and care delivery
172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.